Cargando…

Off-label use of atypical antipsychotics- Where are we?

INTRODUCTION: Nowadays, In the exercise of psychiatric clinical activity, the prescription of atypical antipsychotics is a widespread practice. However, despite the approval in the treatment of psychoses and bipolar affective disorder, where its effectiveness is clearly demonstrated, these drugs are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaz, R. P., Martins, J., Costa, A. L., Brás, J., Sousa, R., Almeida, E., Abreu, J., Castro, N., Andrade, R., Gil, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434096/ http://dx.doi.org/10.1192/j.eurpsy.2023.681

Ejemplares similares

Suicide among physicians: what do we know about it?
por: Vaz, R. P., et al.
Publicado: (2023)

Off-label indications for atypical antipsychotics: A systematic review
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2004)

Summary of the Comparative Effectiveness Review on Off-Label Use of Atypical Antipsychotics
por: Maher, Alicia R., et al.
Publicado: (2012)

Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatment
por: Sousa, R., et al.
Publicado: (2023)

Postpartum Delirium: A Psychosis Born in the 18th Century
por: Martins, J. R., et al.
Publicado: (2023)

Psychosis in Parkinson’s Disease: a Case Report of Diagnosis and Management
por: Andrade, R. P. L., et al.
Publicado: (2023)

National trends in off-label use of atypical antipsychotics in children and adolescents in the United States
por: Sohn, Minji, et al.
Publicado: (2016)

Role of migration in the development of a first episode of psychosis
por: Vaz, R., et al.
Publicado: (2022)

ONLY IN DREAMS: a case report of sleep deprivation psychosis
por: Brás, J., et al.
Publicado: (2022)

Anorexia Nervosa and Gender Dysphoria: A Clinical Case
por: Martins, J., et al.
Publicado: (2022)

“Walking with myself by my side” - non-medical use of Ketamine
por: Vaz, R., et al.
Publicado: (2022)

Editorial: Antipsychotics of New Generation: Where Are We now?
por: Lipina, Tatiana V., et al.
Publicado: (2021)

Can atypical antipsychotic drugs cause hepatotoxicity?
por: André, R., et al.
Publicado: (2021)

Dissociation and emotional dysregulation in pathological personalities related to the fear of SARS-COV-2: a case report
por: Sousa, R., et al.
Publicado: (2022)

Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis
por: Yunusa, Ismaeel, et al.
Publicado: (2022)

Off-label prescribing of antipsychotics: prescribing practices and clinical experiences of Finnish physicians
por: Rautio, N., et al.
Publicado: (2022)

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
por: van Westrhenen, Roos, et al.
Publicado: (2020)

An audit into the monitoring of off-label antipsychotics in primary care
por: Rafi, Damir, et al.
Publicado: (2021)

Walled-off pancreatic necrosis: where are we?
por: Boškoski, Ivo, et al.
Publicado: (2014)

Diversity in orthopaedic trauma: where we are and where we need to be
por: Ortega, Gil, et al.
Publicado: (2021)

Communication skills in medicine: where do we come from and where are we going?
por: Ferreira-Padilla, Guillermo, et al.
Publicado: (2015)

Catatonia and dementia: a case report
por: Almeida, E., et al.
Publicado: (2022)

Off-Label Antipsychotic Prescribing for Persons With Dementia in Assisted Living
por: Wretman, Christopher, et al.
Publicado: (2020)

Atypical Chronic Myeloid Leukemia: Where Are We Now?
por: Crisà, Elena, et al.
Publicado: (2020)

Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
por: Broekema, W. J., et al.
Publicado: (2007)

Update on cervical disc arthroplasty: where are we and where are we going?
por: Jaramillo-de la Torre, Jorge J., et al.
Publicado: (2008)

Characteristics and predictors of off‐label use of antipsychotics in general population sample
por: Pirhonen, Eero, et al.
Publicado: (2022)

Prescribing of Antipsychotic Medication in a Medicaid Population: Use of Polytherapy and Off-Label Dosages
por: Kogut, Stephen J., et al.
Publicado: (2005)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

The modulation of adult neuroplasticity is involved in the mood-improving actions of atypical antipsychotics in an animal model of depression
por: Morais, M, et al.
Publicado: (2017)

Where are we coming from? What are we? Where are we going?
por: Ellis, John R.
Publicado: (1995)

Atypical antipsychotics, more than just an antipsychotic
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2020)

Introduction to sessions on 'Endocrine therapy: where have we come from, where are we at and where are we going to?'
por: Ingle, James N
Publicado: (2008)

Space Exploration: Where we have been, Where we are and Where we are going - A human perspective
por: Tripathi, R K
Publicado: (2005)

Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
por: Bastaki, Kholoud, et al.
Publicado: (2021)

Asenapine, a new sublingual atypical antipsychotic
por: Balaraman, R, et al.
Publicado: (2010)

Pediatric Sepsis Research: Where Are We and Where Are We Going?
por: Massaud-Ribeiro, Letícia, et al.
Publicado: (2022)

Health-related quality of life in patients treated with atypical antipsychotics
por: de Almeida, Juliana L., et al.
Publicado: (2020)

Intensive Care Medicine: Where We Are and Where We Want To Go?
por: Moreno, R. P., et al.
Publicado: (2011)

The influence of atypical antipsychotic drugs on sexual function
por: Just, Marek J
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5t60f7atftiu4fj9omfgtjqv5b